Literature DB >> 11505403

A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan.

M Sagawa1, Y Tsubono, Y Saito, M Sato, I Tsuji, S Takahashi, K Usuda, T Tanita, T Kondo, S Fujimura.   

Abstract

BACKGROUND: In Miyagi Prefecture, Japan, a mass screening program for lung cancer has been conducted since 1982 (miniature chest X-ray for all screenees and sputum cytology for those with a smoking index > or = 600) [smoking index 600 = 30 pack years, the average number of cigarettes smoked per day multiplied by the number of years of regular smoking]. Over 1500 lung carcinomas, including 250 roentgenographically occult lung tumors, were detected and treated up to 1999. In the current study, a nested case-control study was conducted in the population that was screened in 1989 to evaluate the efficacy of the screening program for lung cancer.
METHODS: To reduce self-selection bias, the source population was defined as screenees with negative results in 1989 (284,226 individuals). In the population, 474 individuals died of lung carcinoma during 1992-1994. After exclusion, 328 patients who died of primary lung carcinoma at between ages 40 years and 79 years were defined as the cases. Six controls were supposed to be selected in the source population for each case and matched by gender, year of birth, municipality, and smoking habits. Controls who had died or moved before the matched case was diagnosed were excluded. Finally, 328 cases and 1886 controls were selected. Screening histories were compared, and odds ratios were calculated using conditional logistic regression analysis.
RESULTS: Within the 12 months before diagnosis, 241 of 328 cases (73.5%) had attended the screening compared with 1557 of 1886 controls (82.6%). The smoking-adjusted odds ratio was 0.54 (95% confidence interval, 0.41-0.73).
CONCLUSIONS: The mass screening program for lung cancer in Miyagi Prefecture was capable of reducing by 46% the risk of death from carcinoma of the lung. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11505403     DOI: 10.1002/1097-0142(20010801)92:3<588::aid-cncr1358>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

2.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

Review 3.  Lung cancer screening and its efficacy.

Authors:  Motoyasu Sagawa; Katsuo Usuda; Hirokazu Aikawa; Yuichiro Machida; Makoto Tanaka; Masakatsu Ueno; Tsutomu Sakuma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-10-16

4.  Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.

Authors:  İsmail Ağababaoğlu; Ahmet Önen; Ayşe Banu Demir; Safiye Aktaş; Zekiye Altun; Hasan Ersöz; Aydn Şanl; Nezih Özdemir; Atila Akkoçlu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  The Prefectural Participation Rates of Lung Cancer Screening Had a Negative Correlation with the Lung Cancer Mortality Rates

Authors:  Motoyasu Sagawa; Ryoko Machii; Tomio Nakayama; Takafumi Sugawara; Naoya Ishibashi; Hideki Mitomo; Takashi Kondo; Toshiharu Tabata
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

6.  Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China.

Authors:  Qiong Chen; Liang Yu; Changqing Hao; Jinwu Wang; Shuzheng Liu; Meng Zhang; Shaokai Zhang; Lanwei Guo; Peiliang Quan; Patrick Germain; Yawei Zhang; Xibin Sun
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

7.  The Effect of False-Positive Results on Subsequent Participation in Chest X-ray Screening for Lung Cancer.

Authors:  Akira Sato; Shota Hamada; Yuki Urashima; Shiro Tanaka; Hiroaki Okamoto; Koji Kawakami
Journal:  J Epidemiol       Date:  2016-07-02       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.